SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-23-000079
Filing Date
2023-11-08
Accepted
2023-11-08 16:14:21
Documents
13
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20231108x8k.htm   iXBRL 8-K 44508
2 EX-99.1 amph-20231108xex99d1.htm EX-99.1 708534
  Complete submission text file 0001297184-23-000079.txt   905128

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20231108.xsd EX-101.SCH 3364
4 EX-101.LAB amph-20231108_lab.xml EX-101.LAB 15362
5 EX-101.PRE amph-20231108_pre.xml EX-101.PRE 10386
7 EXTRACTED XBRL INSTANCE DOCUMENT amph-20231108x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 231388020
SIC: 2834 Pharmaceutical Preparations